ADXN Addex Net earnings per share for the last 12 months

Brandmark of Addex Therapeutics Ltd. (ADXN)

The TTM net income per share distribution demonstrates yield dynamics, where -8.79 represents the current metric level. Addex Therapeutics (ADXN) develops small molecules for the therapy of neurological pathologies using allosteric modulation. The business focuses on combating dyskinesia in Parkinson's disease, although project success depends on patents and clinical trial outcomes amid fierce competition.

addextherapeutics.com (ADXN) - Earnings per share for the trailing year from 07/04/2022 to 11/13/2026

Analytical breakdowns for Addex Therapeutics Ltd. (ADXN)

- stock price and consensus target price:
Stock Price Addex Therapeutics|ADXN - Average Forecast Price
- market capitalization data:
Market Valuation Addex Therapeutics Ltd|ADXN - Business Value
- balance sheet net asset value indicators:
Accounting Value per Share Addex Therapeutics|ADXN - Accounting Value of Company|Market Cap to Net Assets Ratio addextherapeutics.com|ADXN - Aggregate Business Assets
- debt burden and liquidity indicators:
Total Debt to Capital Addex Therapeutics|ADXN - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Addex Therapeutics, Ltd.|ADXN - Company Cumulative Debt|Debt to Book Capitalization Ratio Addex Therapeutics Ltd|ADXN - Company Long-Term Loans and Borrowings|Company Short-Term Debts Addex Therapeutics|Quick Liquidity addextherapeutics.com
- earnings and valuation multiples indicators:
ADXN - Profit After Tax|Projected Future Earnings Addex Therapeutics|ADXN - Market Cap to Earnings|Projected Price to Earnings Addex Therapeutics Ltd|ADXN - PEG Multiple|Enterprise Value to EBITDA Ratio Addex Therapeutics Ltd|ADXN - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Addex Therapeutics|ADXN - Net earnings per share for the last four quarters|Quarterly EPS earnings growth addextherapeutics.com|ADXN - Net earnings per share growth this year|Net earnings per share growth forecast for next year Addex Therapeutics
Basic company analysis:ADXN - Addex Therapeutics
Manufactured products of Addex Therapeutics Ltd.

The development of allosteric modulators by Addex Therapeutics (ADXN) requires high R&D expenditures without current sales. This metric measures the final net income allocated per share annually. By analyzing the rolling annual earnings per share, an investor assesses the efficiency of the business's capitalization. Negative dynamics reflect a lack of operating leverage. Stagnation of this metric renders the current market valuation of the asset excessively risky.

Competing companies

Biogen Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months neurocrine.com|RGC (Regencell Bioscience Holdings Limited) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months AXSM|Net earnings per share for the last 12 months ACAD|XENE: Earnings per share for the trailing year|Net earnings per share for the last 12 months VKTX (Viking Therapeutics)|Earnings per share for the last four quarters SUPN|Net earnings per share (EPS TTM) CPRX (Catalyst Pharmaceuticals, Inc.)|Earnings per share for the trailing year DNLI|Harmony Pharma - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Biohaven Corp|Amylyx Pharmaceuticals (AMLX) - Earnings per share for the last twelve months|trevitherapeutics.com - Earnings per share for the trailing year|PRAX (Praxis Precision Medicines, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Anavex|Earnings per share for the last twelve months CeriBell Corp (CBLL)|PRTA: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) ALEC (Alector)|annexonbio.com (ANNX) - Net earnings per one share for the last twelve months|OMER: Net earnings per share for the last 12 months|NGNE - Net earnings per share (EPS TTM)|ACIU (AC Immune Corp) - Net earnings per share for the last 12 months|VYGR: Earnings per share for the last four quarters|NMRA (Neumora Therapeutics) - Net earnings per share (EPS TTM)|scilexholding.com (SCLX) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) TVGN|Net earnings per share for the last 12 months alphacognition.com ACOG|Earnings per share for the last twelve months Cognition Therapeutics CGTX|Net earnings per share for the last four quarters Inhibikase Pharma (IKT)|Cassava Sciences, Inc. - Net earnings per share (EPS TTM)|ASRT - Net earnings per share (EPS TTM)|COYA: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months VTGN|Net earnings per share for the last 12 months OVID|Earnings per share for the last 12 months ABOS (Acumen Pharmaceuticals, Inc)|Earnings per share for the last twelve months CervoMed Inc. (CRVO)|alteritytherapeutics.com - Earnings per share for the last 12 months|Earnings per share for the last twelve months Clene CLNN|PEPG: Earnings per share for the last 12 months|Jupiter Neurosciences Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Relmada Corp|ANVS (Annovis Bio, Inc.) - Net earnings per share for the last 12 months|Grace Therapeutics (GRCE) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Firefly Neuroscience|KLTO: Earnings per share for the trailing year|Earnings per share for the last twelve months NeuroSense Therapeutics (NRSN)|RVPH - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) MTVA (MetaVia)|Net earnings per share (EPS TTM) neuraxis.com NRXS|Helius Medical Technologies Inc. - Net earnings per share (EPS TTM)|PASG (Passage Bio, Inc.) - Earnings per share for the last 12 months|NEUP: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months NERV|ATHA (Athira Pharma, Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Alzamend ALZN|Net earnings per share for the last 12 months CYCN (Cyclerion Therapeutics)|protagenic.com - Earnings per share for the last 12 months|Pasithea Therapeutics Corp. - Net earnings per share for the last 12 months|Earnings per share for the trailing year CRGT|ATXI: Net earnings per share for the last 12 months|brainstorm-cell.com - Earnings per share for the last four quarters|CARA: Net earnings per share (EPS TTM)|Chromocell Therapeutics Corp - Earnings per share for the trailing year|ELYM (Eliem Therapeutics, Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Intra-Cellular ITCI|Earnings per share for the last twelve months Longboard Pharmaceuticals (LBPH)|MRNS (marinuspharma.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) NKGN (NKGen Biotech)|Net earnings per share (EPS TTM) NeuroBo Pharmaceuticals Inc NRBO|SAGE - Earnings per share for the last twelve months|Earnings per one share for the last 12 months SNPX|TRVN: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Vigil Neuroscience, Inc. (VIGL)|Net earnings per share for the last 12 months WENA|Net earnings per share (EPS TTM) Cerevel Therapeutics Inc